Open an Account
search icon
4
NOTIFICATIONS
Best Algo trading app in India
Bigul

Board Meeting Intimation for Consideration Of Unaudited Financial Results For The Quarter And Half-Year Ending 30 September 2018.

 BAJAJ FINANCE LIMITEDhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 23/10/2018 ,inter alia, to consider and approve Pursuant to Regulation 29 of the SEBI Listing Regulations, 2015, notice is hereby given that a meeting of the Board of Directors of the Company will be held on Tuesday, 23 October 2018, inter alia, to consider the unaudited financial results for the quarter and half year ending 30 September 2018.
26-09-2018
Bigul

Announcement under Regulation 30 (LODR)-Retirement

 Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, this is to inform you that the Board of Directors of the Company at its Meeting held on 17 September 2018 has appointed Shri Vijay R as the Company Secretary and Compliance Officer of the Company with effect from 1 October 2018 in place of Shri Anant Damle who will retire as Company Secretary and Compliance Officer with effect from 30 September 2018.
17-09-2018
Bigul

Many reasons why Bajaj Finance stock will remain an outperformer

 Strong loan growth thanks to increasing aspirational buyers and healthy asset quality could keep story intact
02-09-2018
Bigul

Announcement under Regulation 30 (LODR)-Issue of Securities

 Intimation of allotment of Secured Redeemable Non-Convertible Debentures on Private Placement basis
25-08-2018
Bigul

Announcement under Regulation 30 (LODR)-Issue of Securities

 Intimation of allotment of Secured Redeemable Non-Convertible Debentures on Private Placement basis
13-08-2018
Bigul

Announcement under Regulation 30 (LODR)-Issue of Securities

 Intimation of allotment of Secured Redeemable Non-Convertible Debentures on Private Placement basis
27-07-2018

Screener: Stocks which beat the Sensex in the last three months

 By Suhani Adilabadkar This screener identifies stocks which surpassed Sensex growth over the past three months and have grown above 10%. And there is only one midcap in the list - Yes Bank. After a stellar performance over the past 2-3 years, mid and small caps have lost their Midas touch since January. Large caps or the hulks of Indian economy are still holding up amidst global volatility, so that the decline within the smaller scrips is not as visible. From a lifetime high in January 2018, S&P; BSE Small cap & Midcap indices have declined 18% and 15% respectively this year. Mid & small caps are regarded as growth fountains by domestic mutual funds & HNIs investing for their high upside potential. But what happens when the global tailwinds transform into headwinds for these ‘low priced high value’ stocks. By the end of 2017, the Indian rupee was perched at Rs 63.83 to the dollar, had gained 6% during the year & brent crude was looming around $65 per barrel. But with the onset of 2018, oil rise and rupee depreciation along with trade war fears, rising inflation took its toll. Though the slide began in February, the actual bloodbath started from May with Crude touching $80 per barrel and Indian rupee crossing 68 levels on 18th May 2018. The oil price hike leading to rising input costs along with inflation creeping back to every boardroom tete-a-tete throttled small & mid sized companies recuperating from demono fears & vigorous GST exercise. S&P; BSE Small & Midcaps have fallen 14% & 11% since May this year. BSE Sensex on the on other hand has gained 4% from May and 8% since the beginning of the year. Largecaps like Tata Consultancy, Indian IT bellweather have beaten Sensex growth and been exhibiting strong momentum over the last few quarters. Apart from the double digit revenue & PAT growth YOY, that TCS saw, operating margin came at 25% in June quarter compared to 23.40% corresponding quarter previous year. The top slot in the screener however, goes to Bajaj Finance, whose share price has gained strongly over the last 6 months and has been an enormous value creator. Bajaj Finance entered the screener on 20th July displacing TCS from the top after the announcement of its June quarter results. Though the valuations look expensive, it delivered a strong performance with consolidated PAT, NII & AUM growing at 81%, 46% & 35% YOY respectively and the best asset quality in NBFC sector. Hindustan Unilever is the barometer of Indian FMCG growth. June quarter is the third consecutive robust double digit growth for the FMCG behemoth. Volume growth of 12% and margin expansion of 100 basis points along with robust EBDITA growth of 21% YOY makes it one of the most sought out large cap scrips. Though a low base effect, crude volatility and currency headwinds might upset its growth trajectory in the coming quarters, normal monsoon, growing rural incomes and operational efficiencies will help it to chart its own course through global & domestic turbulence. Reliance Industries, Sun Pharma and Yes Bank are yet to come out with their June numbers. Reliance industries, the petrochemical & refining behemoth commands high premium valuation as its Jamnagar refinery with processing capacity of 1.24 million barrels of crude per day can refine the cheapest crude in the world providing high & stable GRMs in oil business. Reliance’s telecom business Jio has become profitable from December quarter garnering 200 million subscriber by June and retail revenues have doubled on yearly basis. RIL is the highest customs, excise, GST & income tax payer in the country. Reliance Industries alone accounts for about 9% of India’s total merchandise exports. The stock with its huge market capitalization provides the much needed resilience during hard times of global uncertainty. The scrip has gained 15% since Jan 2018. Sun Pharma, India’s largest and world's fifth largest specialty generic pharmaceutical company is another large cap which has bounced back over the past 3 months. The stock has been rising mainly from June as its Halol facility which contributes around 40% of its revenues received EIR from USFDA with the inspection getting closed. Sun Pharma has recently received US FDA approval for INFUGEM for intravenous use in a ready-to-administer (RTA) bag. INFUGEM, is the first product approval from Halol after the EIR was received in June. The stock jumped 3% after this announcement on 19th June . Yes Bank is the only midcap in the screener and is the most coveted one among mid cap banking stocks. With stable NIM of 3.4% & double digit PAT & NII growth both yearly and QOQ, Yes Bank has been the recipient of investor enthusiasm. So don’t chuck out your small & mid cap stocks just yet, as they are long term value creators if bought at right valuations. But these large caps are like reliable boats, extremely essential if you want to ride through storms of global uncertainty. Suhani Adilabadkar is a Research Analyst registered with SEBI ((INH200003240)) She has done PGDBA (Finance), MS (Finance) and a Fellowship from Insurance Institute of India. She maintains a blog at oasisfundamentals.blogspot.in. Disclaimer: Investing in stock markets is subject to market risks. Neither Trendlyne nor the author is liable for losses including consequential losses, claims, or expenses incurred by third parties from following research reports and advisory analysis available on Trendlyne.
23-07-2018
Bigul

Disclosure of Voting results of AGM (Regulation 44(3) of SEBI (LODR) Regulations, 2015)

 Bajaj Finance Ltd has informed BSE regarding the details of Voting results of AGM, under Regulation 44(3) of SEBI (LODR) Regulations, 2015. Kindly Click here
20-07-2018
Bigul

Disclosure of Voting results of AGM (Regulation 44(3) of SEBI (LODR) Regulations, 2015)

 Bajaj Finance Ltd has informed BSE regarding the details of Voting results of AGM, under Regulation 44(3) of SEBI (LODR) Regulations, 2015. Kindly Click here
20-07-2018
Bigul

Bajaj Finance, Finserv set new peak post Q1 nos

 Bajaj Finance on Thursday reported an 81.40 per cent YoY jump in consolidated net profit at Rs 835.89 crore for April-June.
20-07-2018
Next Page
Close

Let's Open Free Demat Account